10-QPeriod: Q2 FY2023

ECOLAB INC. Quarterly Report for Q2 Ended Jun 30, 2023

Filed August 3, 2023For Securities:ECL

Summary

Ecolab Inc. reported solid financial results for the second quarter and first six months of 2023, demonstrating revenue growth and improved profitability. Net sales increased by 8% year-over-year for both periods, driven by a combination of price increases and volume growth across most segments. The company saw particular strength in its Global Industrial and Global Institutional & Specialty segments, which experienced double-digit organic sales growth. Profitability also improved, with reported operating income up 14% and 23% for the respective periods. The company is actively managing restructuring initiatives aimed at cost savings, with a significant portion of the anticipated charges expected to be completed by 2024. Despite ongoing inflationary pressures and global economic uncertainties, Ecolab maintained a strong financial position. The company's liquidity remains robust, supported by consistent cash flow from operations. Management is focused on strategic growth initiatives, including targeted acquisitions, while also returning capital to shareholders through dividends and share repurchases. Ecolab's diversified business model and disciplined approach to cost management position it well to navigate the current economic landscape.

Financial Highlights

53 data points
Beta

Revenue

$3.85B

39.4% Gross Margin

Net Income

$329.70M

8.6% Net Margin

EPS (Diluted)

$1.15

Total Assets

$21.46B

Cash & Equivalents

$554.20M

Free Cash Flow

$401.40M

Financial Statements
Beta
Revenue$3.85B
Cost of Revenue$2.33B
Gross Profit$1.52B
SG&A Expenses$1.01B
Operating Income$484.70M
Interest Expense$82.70M
Net Income$329.70M
EPS (Basic)$1.16
EPS (Diluted)$1.15
Shares Outstanding (Basic)284.90M
Shares Outstanding (Diluted)286.30M

Key Highlights

  • 1Net sales increased by 8% year-over-year for both the second quarter and the first six months of 2023, reaching $3.85 billion and $7.42 billion, respectively.
  • 2Organic sales grew by 9% in the second quarter and 11% in the first six months, indicating strong underlying business performance driven by pricing and volume.
  • 3Operating income saw significant increases, up 14% to $484.7 million in Q2 and 23% to $836.3 million in the first six months, reflecting effective cost management and pricing strategies.
  • 4Restructuring initiatives, including the Combined Program, are underway with expected pre-tax charges of $195 million, aimed at achieving significant annualized cost savings.
  • 5Acquisition of Chemlink Laboratories LLC in May 2023 strengthens the Global Institutional & Specialty segment.
  • 6The company's financial position remains strong, with total assets of $21.5 billion and a net debt to EBITDA ratio of 3.0x as of June 30, 2023.
  • 7Diluted EPS increased by 6% to $1.15 in Q2 and 18% to $1.97 in the first six months, demonstrating improved profitability on a per-share basis.

Frequently Asked Questions

Ecolab's sales growth was primarily driven by a combination of price changes and volume increases across its segments. Pricing actions were a significant contributor, helping to offset cost inflation, while positive volume trends were observed in key segments like Global Industrial and Global Institutional & Specialty.

Ecolab is actively pursuing restructuring initiatives, notably the 'Combined Program,' which is expected to incur $195 million in pre-tax charges. These programs are designed to achieve significant cost savings, with an estimated $175 million in annualized savings expected from the Combined Program by 2024. The company is also progressing with other initiatives like the 'Institutional Advancement Program' and 'Accelerate 2020'.

The Global Industrial and Global Institutional & Specialty segments showed robust performance with double-digit organic sales growth. The Global Healthcare & Life Sciences segment experienced modest growth, slightly offset by soft demand in the life sciences industry. The 'Other' segment, including Pest Elimination, also showed strong growth.

Ecolab maintains a strong financial position with total assets of $21.5 billion and a healthy net debt to EBITDA ratio of 3.0x. The company generated strong cash flow from operations ($771.6 million in the first six months of 2023), enabling it to fund operations, investments, and return capital to shareholders. Liquidity is further supported by a $2.0 billion revolving credit facility.